Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flecainide: its value and danger

R Malik1, K A Ellenbogen, B S Stambler

  • 1Department of Medicine, Medical College of Virginia, Richmond 23298.

Heart Disease and Stroke : a Journal for Primary Care Physicians
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Machine learned interatomic potential for dispersion strengthened plasma facing components.

The Journal of chemical physics·2023
Same author

Temporal endurance of exercise-induced benefits on hippocampus-dependent memory and synaptic plasticity in female mice.

Neurobiology of learning and memory·2022
Same author

Author Correction: Microglial activation increases cocaine self-administration following adolescent nicotine exposure.

Nature communications·2021
Same author

HDAC3 Activity within the Nucleus Accumbens Regulates Cocaine-Induced Plasticity and Behavior in a Cell-Type-Specific Manner.

The Journal of neuroscience : the official journal of the Society for Neuroscience·2021
Same author

Systemic HDAC3 inhibition ameliorates impairments in synaptic plasticity caused by simulated galactic cosmic radiation exposure in male mice.

Neurobiology of learning and memory·2020
Same author

Explicit Multielement Extension of the Spectral Neighbor Analysis Potential for Chemically Complex Systems.

The journal of physical chemistry. A·2020

Flecainide effectively treats paroxysmal supraventricular tachycardia and nonsustained ventricular arrhythmias in patients without heart disease. Its use is limited for life-threatening sustained ventricular arrhythmias.

Area of Science:

  • Cardiology
  • Pharmacology
  • Electrophysiology

Background:

  • Flecainide is a Class Ic antiarrhythmic drug.
  • Its efficacy and safety profile are well-established for specific arrhythmias.

Purpose of the Study:

  • To evaluate the therapeutic role of flecainide in managing supraventricular and ventricular arrhythmias.
  • To delineate its utility in patients with and without structural heart disease.

Main Methods:

  • Review of existing clinical data and studies on flecainide.
  • Analysis of flecainide's mechanism of action and clinical applications.

Main Results:

  • Flecainide is a potent treatment for paroxysmal supraventricular tachycardia in patients without structural heart disease.

Related Experiment Videos

  • It demonstrates utility in managing debilitating nonsustained ventricular arrhythmias in similar patient populations.
  • Its role in life-threatening sustained ventricular arrhythmias is limited.

    • Conclusions:

    • Flecainide is a valuable therapeutic option for specific supraventricular and nonsustained ventricular arrhythmias.
    • Careful patient selection, particularly regarding structural heart disease, is crucial for optimal outcomes.
    • It is not a primary choice for managing life-threatening sustained ventricular arrhythmias.